Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.
- DOI
- 10.2147/opth.s186074
- Published
- 2018
- Container
- Clinical ophthalmology (Auckland, N.Z.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/opth.s186074,
title = {Efficacy and safety of glycyrrhizin 2.5\% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.},
author = {Burillon C and Chiambaretta F and Pisella PJ},
year = {2018},
journal = {Clinical ophthalmology (Auckland, N.Z.)},
doi = {10.2147/opth.s186074},
url = {https://doi.org/10.2147/opth.s186074}
}RIS
TY - JOUR TI - Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study. AU - Burillon C AU - Chiambaretta F AU - Pisella PJ PY - 2018 JO - Clinical ophthalmology (Auckland, N.Z.) DO - 10.2147/opth.s186074 UR - https://doi.org/10.2147/opth.s186074 ER -
APA
C, B., F, C., & PJ, P. (2018). Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s186074
Source records
- pubmed · retrieved 2026-09-26T05:56:31.565Z
- europe-pmc · retrieved 2026-09-26T05:56:31.575Z
- hal · retrieved 2026-09-26T05:56:31.599Z